{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:43:18Z","timestamp":1791117798376,"version":"4.1.0"},"reference-count":72,"publisher":"JLE","issue":"S1","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Dermatol"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1684\/ejd.2014.2505","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T15:01:04Z","timestamp":1696863664000},"page":"4-11","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Nuclear receptor peroxisome proliferator activated receptor (PPAR) \u03b2\/\u03b4 in skin wound healing and cancer"],"prefix":"10.1684","volume":"25","author":[{"given":"Alexandra","family":"Montagner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Wahli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguan Soon","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18929","published-online":{"date-parts":[[2015,6,24]]},"reference":[{"key":"2505_CR1","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.bbalip.2007.02.004","volume":"1771","author":"L. Michalik","year":"2007","unstructured":"Michalik L, Wahli W. Peroxisome proliferator-activated receptors (PPARs) in skin health, repair and disease. Biochim Biophys Acta 2007; 1771: 991\u20138.","journal-title":"Biochim Biophys Acta"},{"key":"2505_CR2","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.tem.2012.05.001","volume":"23","author":"W. Wahli","year":"2012","unstructured":"Wahli W, Michalik L. PPARs at the crossroads of lipid signaling and inflammation. Trends Endocrinol Metab 2012; 23: 351\u201363.","journal-title":"Trends Endocrinol Metab"},{"key":"2505_CR3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0092-8674(00)80726-6","volume":"97","author":"V. Laudet","year":"1999","unstructured":"Laudet V, Auwerx J, Gustafsson J, Wahli W. A unified nomenclature system for the nuclear receptor superfamily. Cell 1999; 97: 161\u20133.","journal-title":"Cell"},{"key":"2505_CR4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1515\/bmc-2012-0035","volume":"4","author":"A. Montagner","year":"2013","unstructured":"Montagner A, Wahli W. Contributions of peroxisome proliferatoractivated receptor \u03b2\/\u03b4 to skin health and disease. BioMol Concepts 2013; 4: 53\u201364.","journal-title":"BioMol Concepts"},{"key":"2505_CR5","first-page":"w13071","volume":"140","author":"A. Yessoufou","year":"2010","unstructured":"Yessoufou A, Wahli W. Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels. Swiss Med Wkly 2010; 140: w13071.","journal-title":"Swiss Med Wkly"},{"key":"2505_CR6","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1124\/pr.58.4.5","volume":"58","author":"L. Michalik","year":"2006","unstructured":"Michalik L, Auwerx J, Berger JP, et al. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacol Rev 2006; 58: 726\u201341.","journal-title":"Pharmacol Rev"},{"key":"2505_CR7","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.bbrc.2008.04.086","volume":"371","author":"E.E. Girroir","year":"2008","unstructured":"Girroir EE, Hollingshead HE, He P, Zhu B, Perdew GH, Peters JM. Quantitative expression patterns of peroxisome proliferator-activated receptor-beta\/delta (PPARbeta\/delta) protein in mice. Biochem Biophys Res Commun 2008; 371: 456\u201361.","journal-title":"Biochem Biophys Res Commun"},{"key":"2505_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1517\/14728222.8.1.39","volume":"8","author":"N.S. Tan","year":"2004","unstructured":"Tan NS, Michalik L, Desvergne B, Wahli W. Peroxisome proliferator-activated receptor-beta as a target for wound healing drugs. Expert Opin Ther Targets 2004; 8: 39\u201348.","journal-title":"Expert Opin Ther Targets"},{"key":"2505_CR9","first-page":"83","volume":"132","author":"W. Wahli","year":"2002","unstructured":"Wahli W. Peroxisome proliferator-activated receptors (PPARs): from metabolic control to epidermal wound healing. Swiss Med Wkly 2002; 132: 83\u201391.","journal-title":"Swiss Med Wkly"},{"key":"2505_CR10","doi-asserted-by":"publisher","first-page":"e83300","DOI":"10.1371\/journal.pone.0083300","volume":"8","author":"N. Rotman","year":"2013","unstructured":"Rotman N, Guex N, Gouranton E, Wahli W. PPAR- interprets a chromatin signature of pluripotency to promote embryonic differentiation at gastrulation. PloS one 2013; 8: e83300.","journal-title":"PloS one"},{"key":"2505_CR11","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1046\/j.1523-1747.2003.12387.x","volume":"121","author":"P. Coulombe","year":"2003","unstructured":"Coulombe P. Wound epithelialization: accelerating the pace of discovery. J Invest Dermatol 2003; 121: 219\u201330.","journal-title":"J Invest Dermatol"},{"key":"2505_CR12","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1089\/wound.2012.0414","volume":"2","author":"H.P. Ehrlich","year":"2013","unstructured":"Ehrlich HP. A snapshot of direct cell-cell communications in wound healing and scarring. Adv Wound Care 2013; 2: 113\u201321.","journal-title":"Adv Wound Care"},{"key":"2505_CR13","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1524-475X.2011.00673.x","volume":"19","author":"G.S. Schultz","year":"2011","unstructured":"Schultz GS, Davidson JM, Kirsner RS, Bornstein P, Herman IM. Dynamic reciprocity in the wound microenvironment. Wound Repair Regen 2011; 19: 134\u201348.","journal-title":"Wound Repair Regen"},{"key":"2505_CR14","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1152\/physrev.2003.83.3.835","volume":"83","author":"S. Werner","year":"2003","unstructured":"Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003; 83: 835\u201370.","journal-title":"Physiol Rev"},{"key":"2505_CR15","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/sj.jid.5700811","volume":"127","author":"B.M. Stramer","year":"2007","unstructured":"Stramer BM, Mori R, Martin P. The inflammation-fibrosis link? A Jekyll and Hyde role for blood cells during wound repair. J Invest Dermatol 2007; 127: 1009\u201317.","journal-title":"J Invest Dermatol"},{"key":"2505_CR16","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.tcb.2005.09.002","volume":"15","author":"P. Martin","year":"2005","unstructured":"Martin P, Leibovich SJ. Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol 2005; 15: 599\u2013607.","journal-title":"Trends Cell Biol"},{"key":"2505_CR17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/1534734609337151","volume":"8","author":"R. Blakytny","year":"2009","unstructured":"Blakytny R, Jude EB. Altered molecular mechanisms of diabetic foot ulcers. Int J Low Extrem Wounds 2009; 8: 95\u2013104.","journal-title":"Int J Low Extrem Wounds"},{"key":"2505_CR18","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/j.1743-6109.2006.00155.x","volume":"14","author":"H. Galkowska","year":"2006","unstructured":"Galkowska H, Wojewodzka U, Olszewski WL. Chemokines, cytokines, and growth factors in keratinocytes and dermal endothelial cells in the margin of chronic diabetic foot ulcers. Wound Repair Regen 2006; 14: 558\u201365.","journal-title":"Wound Repair Regen"},{"key":"2505_CR19","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1172\/JCI32169","volume":"117","author":"H. Brem","year":"2007","unstructured":"Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J Clin Invest 2007; 117: 1219\u201322.","journal-title":"J Clin Invest"},{"key":"2505_CR20","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1111\/j.1582-4934.2009.00816.x","volume":"14","author":"S.A. Ham","year":"2010","unstructured":"Ham SA, Kim HJ, Kim HJ, et al. PPARdelta promotes wound healing by up-regulating TGF-beta1-dependent or-independent expression of extracellular matrix proteins. J Cell Mol Med 2010; 14: 1747\u201359.","journal-title":"J Cell Mol Med"},{"key":"2505_CR21","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1083\/jcb.200011148","volume":"154","author":"L. Michalik","year":"2001","unstructured":"Michalik L, Desvergne B, Tan NS, et al. Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)alpha and PPARbeta mutant mice. J Cell Biol 2001; 154: 799\u2013814.","journal-title":"J Cell Biol"},{"key":"2505_CR22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1042\/BST0320097","volume":"32","author":"N.S. Tan","year":"2004","unstructured":"Tan NS, Michalik L, Di-Po\u00ef N, Desvergne B, Wahli W. Critical roles of the nuclear receptor PPARbeta (peroxisome-proliferator-activated receptor beta) in skin wound healing. Biochem Soc Trans 2004; 32: 97\u2013102.","journal-title":"Biochem Soc Trans"},{"key":"2505_CR23","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S1097-2765(02)00646-9","volume":"10","author":"N. Di-Po\u00ef","year":"2002","unstructured":"Di-Po\u00ef N, Tan NS, Michalik L, Wahli W, Desvergne B. Antiapoptotic role of PPARbeta in keratinocytes via transcriptional control of the Akt1 signaling pathway. Mol Cell 2002; 10: 721\u201333.","journal-title":"Mol Cell"},{"key":"2505_CR24","doi-asserted-by":"publisher","first-page":"7161","DOI":"10.1128\/MCB.00436-07","volume":"27","author":"N.S. Tan","year":"2007","unstructured":"Tan NS, Icre G, Montagner A, Bordier-ten-Heggeler B, Wahli W, Michalik L. The nuclear hormone receptor peroxisome proliferator-activated receptor beta\/delta potentiates cell chemotactism, polarization, and migration. Mol Cell Biol 2007; 27: 7161\u201375.","journal-title":"Mol Cell Biol"},{"key":"2505_CR25","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/12971","volume":"1","author":"G.S. Ashcroft","year":"1999","unstructured":"Ashcroft GS, Yang X, Glick AB, et al. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol 1999; 1: 260\u20136.","journal-title":"Nat Cell Biol"},{"key":"2505_CR26","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/S0960-9822(03)00396-8","volume":"13","author":"P. Martin","year":"2003","unstructured":"Martin P, D\u2019Souza D, Martin J, et al. Wound healing in the PU.1 null mouse\u2013tissue repair is not dependent on inflammatory cells. Curr Biol 2003; 13: 1122\u20138.","journal-title":"Curr Biol"},{"key":"2505_CR27","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/j.1742-481X.2008.00457.x","volume":"5","author":"J. d. B. D. V. D. Acosta","year":"2008","unstructured":"Acosta JB, del Barco DG, Vera DC, et al. The pro-inflammatory environment in recalcitrant diabetic foot wounds. Int Wound J 2008; 5: 530\u20139.","journal-title":"Int Wound J"},{"key":"2505_CR28","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/sj.jid.5701011","volume":"128","author":"M.Q. Man","year":"2008","unstructured":"Man MQ, Barish GD, Schmuth M, et al. Deficiency of PPARbeta\/ delta in the epidermis results in defective cutaneous permeability barrier homeostasis and increased inflammation. J Invest Dermatol 2008; 128: 370\u20137.","journal-title":"J Invest Dermatol"},{"key":"2505_CR29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1126\/science.1087344","volume":"302","author":"C.H. Lee","year":"2003","unstructured":"Lee CH, Chawla A, Urbiztondo N, et al. Transcriptional repression of atherogenic inflammation: modulation by PPARdelta. Science 2003; 302: 453\u20137.","journal-title":"Science"},{"key":"2505_CR30","first-page":"463","volume":"9","author":"K.S. Kilgore","year":"2008","unstructured":"Kilgore KS, Billin AN. PPARbeta\/delta ligands as modulators of the inflammatory response. Curr Opin Investig Drugs 2008; 9: 463\u20139.","journal-title":"Curr Opin Investig Drugs"},{"key":"2505_CR31","doi-asserted-by":"publisher","first-page":"6712","DOI":"10.1073\/pnas.1031789100","volume":"100","author":"J.S. Welch","year":"2003","unstructured":"Welch JS, Ricote M, Akiyama TE, Gonzalez FJ, Glass CK. PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages. Proc Natl Acad Sci USA 2003; 100: 6712\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2505_CR32","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1083\/jcb.200809028","volume":"184","author":"H.C. Chong","year":"2009","unstructured":"Chong HC, Tan MJ, Philippe V, et al. Regulation of epithelialmesenchymal IL-1 signaling by PPARbeta\/delta is essential for skin homeostasis and wound healing. J Cell Biol 2009; 184: 817\u201331.","journal-title":"J Cell Biol"},{"key":"2505_CR33","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jdermsci.2013.07.008","volume":"72","author":"N.S. Greaves","year":"2013","unstructured":"Greaves NS, Ashcroft KJ, Baguneid M, Bayat A. Current understanding of molecular and cellular mechanisms in fibroplasia and angiogenesis during acute wound healing. J Dermatol Sci 2013; 72: 206\u201317.","journal-title":"J Dermatol Sci"},{"key":"2505_CR34","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1089\/wound.2011.0348","volume":"2","author":"M.S. Wietecha","year":"2013","unstructured":"Wietecha MS, Dipietro LA. Therapeutic Approaches to the Regulation of Wound Angiogenesis. Adv Wound Care 2013; 2: 81\u20136.","journal-title":"Adv Wound Care"},{"key":"2505_CR35","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/med.10024","volume":"23","author":"A. Martin","year":"2003","unstructured":"Martin A, Komada MR, Sane DC. Abnormal angiogenesis in diabetes mellitus. Med Res Rev 2003; 23: 117\u201345.","journal-title":"Med Res Rev"},{"key":"2505_CR36","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.3748\/wjg.v12.i17.2721","volume":"12","author":"K.A. Ekmektzoglou","year":"2006","unstructured":"Ekmektzoglou KA, Zografos GC. A concomitant review of the effects of diabetes mellitus and hypothyroidism in wound healing. World J Gastroenterol 2006; 12: 2721\u20139.","journal-title":"World J Gastroenterol"},{"key":"2505_CR37","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1042\/BSR20110102","volume":"32","author":"P. Zhu","year":"2012","unstructured":"Zhu P, Goh YY, Chin HFA, Kersten S, Tan NS. Angiopoietin-like 4: a decade of research. Biosci Rep 2012; 32: 211\u20139.","journal-title":"Biosci Rep"},{"key":"2505_CR38","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.2353\/ajpath.2010.100129","volume":"177","author":"Y.Y. Goh","year":"2010","unstructured":"Goh YY, Pal M, Chong HC, et al. Angiopoietin-like 4 interacts with integrins beta1 and beta5 to modulate keratinocyte migration. Am J Pathol 2010; 177: 2791\u2013803.","journal-title":"Am J Pathol"},{"key":"2505_CR39","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1038\/mt.2014.102","volume":"22","author":"H.C. Chong","year":"2014","unstructured":"Chong HC, Chan JSK, Goh CQ, et al. Angiopoietin-like 4 stimulates STAT3-mediated iNOS expression and enhances angiogenesis to accelerate wound healing in diabetic mice. Mol Ther 2014; 22: 1593\u2013604.","journal-title":"Mol Ther"},{"key":"2505_CR40","doi-asserted-by":"publisher","first-page":"3990","DOI":"10.1182\/blood-2011-01-328716","volume":"118","author":"R.L. Huang","year":"2011","unstructured":"Huang RL, Teo Z, Chong HC, et al. ANGPTL4 modulates vascular junction integrity by integrin signaling and disruption of intercellular VE-cadherin and claudin-5 clusters. Blood 2011; 118: 3990\u20134002.","journal-title":"Blood"},{"key":"2505_CR41","doi-asserted-by":"publisher","first-page":"e25377","DOI":"10.1371\/journal.pone.0025377","volume":"6","author":"M. Pal","year":"2011","unstructured":"Pal M, Tan MJ, Huang RL, et al. Angiopoietin-like 4 regulates epidermal differentiation. PloS one 2011; 6: e25377.","journal-title":"PloS one"},{"key":"2505_CR42","doi-asserted-by":"publisher","first-page":"32999","DOI":"10.1074\/jbc.M110.108175","volume":"285","author":"Y.Y. Goh","year":"2010","unstructured":"Goh YY, Pal M, Chong HC, et al. Angiopoietin-like 4 interacts with matrix proteins to modulate wound healing. J Biol Chem 2010; 285: 32999\u20133009.","journal-title":"J Biol Chem"},{"key":"2505_CR43","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/S0955-0674(02)00361-7","volume":"14","author":"P. Bornstein","year":"2002","unstructured":"Bornstein P, Sage EH. Matricellular proteins: extracellular modulators of cell function. Curr Opin Cell Biol 2002; 14: 608\u201316.","journal-title":"Curr Opin Cell Biol"},{"key":"2505_CR44","first-page":"965","volume":"29","author":"J.S.K. Chan","year":"2014","unstructured":"Chan JSK, Teo Z, Sng MK, Tan NS. Probing for protein-protein interactions during cell migration: limitations and challenges. Histol Histopathol 2014; 29: 965\u201376.","journal-title":"Histol Histopathol"},{"key":"2505_CR45","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1517\/13543784.17.10.1465","volume":"17","author":"A.N. Billin","year":"2008","unstructured":"Billin AN. PPAR-beta\/delta agonists for Type 2 diabetes and dyslipidemia: an adopted orphan still looking for a home. Expert Opin Investig Drugs 2008; 17: 1465\u201371.","journal-title":"Expert Opin Investig Drugs"},{"key":"2505_CR46","first-page":"138","volume":"197C","author":"X. Wang","year":"2014","unstructured":"Wang X, Sng MK, Foo S, et al. Early controlled release of peroxisome proliferator-activated receptor \u03b2\/\u03b4 agonist GW501516 improves diabetic wound healing through redox modulation of wound microenvironment. J Control Release 2014; 197C: 138\u201347.","journal-title":"J Control Release"},{"key":"2505_CR47","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1038\/cdd.2010.182","volume":"18","author":"C.R.I. Lam","year":"2011","unstructured":"Lam CRI, Tan MJ, Tan SH, Tang MBY, Cheung PCF, Tan NS. TAK1 regulates SCF expression to modulate PKB- activity that protects keratinocytes from ROS-induced apoptosis. Cell Death Differ 2011; 18: 1120\u20139.","journal-title":"Cell Death Differ"},{"key":"2505_CR48","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1177\/000348941212101206","volume":"121","author":"M. Mizuta","year":"2012","unstructured":"Mizuta M, Hirano S, Ohno S, et al. Expression of reactive oxygen species during wound healing of vocal folds in a rat model. Ann Otol Rhinol Laryngol 2012; 121: 804\u201310.","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"2505_CR49","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ymthe.2005.07.684","volume":"13","author":"S. Roy","year":"2006","unstructured":"Roy S, Khanna S, Nallu K, Hunt TK, Sen CK. Dermal wound healing is subject to redox control. Mol Ther 2006; 13: 211\u201320.","journal-title":"Mol Ther"},{"key":"2505_CR50","unstructured":"American Cancer Society. Cancer Facts & Figure 2014. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2014. Available at: http:\/\/www.cancer.org\/acs\/groups\/content\/ @research\/documents\/webcontent\/acspc-042151.pdf (accessed 02 June 2014)."},{"key":"2505_CR51","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1039\/b302281a","volume":"2","author":"J.C. Ehrhart","year":"2003","unstructured":"Ehrhart JC, Gosselet FP, Culerrier RM, Sarasin A. UVB-induced mutations in human key gatekeeper genes governing signalling pathways and consequences for skin tumourigenesis. Photochem Photobiol Sci 2003; 2: 825\u201334.","journal-title":"Photochem Photobiol Sci"},{"key":"2505_CR52","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.taap.2003.08.019","volume":"195","author":"Y. Matsumura","year":"2004","unstructured":"Matsumura Y, Ananthaswamy HN. Toxic effects of ultraviolet radiation on the skin. Toxicol Appl Pharmacol 2004; 195: 298\u2013308.","journal-title":"Toxicol Appl Pharmacol"},{"key":"2505_CR53","doi-asserted-by":"publisher","first-page":"7546","DOI":"10.1073\/pnas.0709981105","volume":"105","author":"T.T. Schug","year":"2008","unstructured":"Schug TT, Berry DC, Toshkov IA, Cheng L, Nikitin AY, Noy N. Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARbeta\/delta to RAR. Proc Natl Acad Sci USA 2008; 105: 7546\u201351.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2505_CR54","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nrc1254","volume":"4","author":"L. Michalik","year":"2004","unstructured":"Michalik L, Desvergne B, Wahli W. Peroxisome-proliferatoractivated receptors and cancers: complex stories. Nat Rev Cancer 2004; 4: 61\u201370.","journal-title":"Nat Rev Cancer"},{"key":"2505_CR55","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc3214","volume":"12","author":"J.M. Peters","year":"2012","unstructured":"Peters JM, Shah YM, Gonzalez FJ. The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention. Nat Rev Cancer 2012; 12: 181\u201395.","journal-title":"Nat Rev Cancer"},{"key":"2505_CR56","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/mc.20665","volume":"50","author":"O. Rho","year":"2011","unstructured":"Rho O, Kim DJ, Kiguchi K, Digiovanni J. Growth factor signaling pathways as targets for prevention of epithelial carcinogenesis. Mol Carcinog 2011; 50: 264\u201379.","journal-title":"Mol Carcinog"},{"key":"2505_CR57","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/emmm.201302666","volume":"6","author":"A. Montagner","year":"2014","unstructured":"Montagner A, Delgado MB, Tallichet-Blanc C, et al. Src is activated by the nuclear receptor peroxisome proliferator-activated receptor \u03b2\/\u03b4 in ultraviolet radiation-induced skin cancer. EMBO Mol Med 2014; 6: 80\u201398.","journal-title":"EMBO Mol Med"},{"key":"2505_CR58","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1161\/CIRCRESAHA.107.158477","volume":"102","author":"H.J. Kim","year":"2008","unstructured":"Kim HJ, Ham SA, Kim SU, et al. Transforming growth factor-beta1 is a molecular target for the peroxisome proliferator-activated receptor delta. Circ Res 2008; 102: 193\u2013200.","journal-title":"Circ Res"},{"key":"2505_CR59","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/j.0303-6987.2005.00345.x","volume":"32","author":"T. Nijsten","year":"2005","unstructured":"Nijsten T, Geluyckens E, Colpaert C, Lambert J. Peroxisome proliferator-activated receptors in squamous cell carcinoma and its precursors. J Cutan Pathol 2005; 32: 340\u20137.","journal-title":"J Cutan Pathol"},{"key":"2505_CR60","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1582-4934.2003.tb00222.x","volume":"7","author":"O.C. Trifan","year":"2003","unstructured":"Trifan OC, Hla T. Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis. J Cell Mol Med 2003; 7: 207\u201322.","journal-title":"J Cell Mol Med"},{"key":"2505_CR61","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2165\/00128071-200809010-00002","volume":"9","author":"P. Sertznig","year":"2008","unstructured":"Sertznig P, Seifert M, Tilgen W, Reichrath J. Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases. Am J Clin Dermatol 2008; 9: 15\u201331.","journal-title":"Am J Clin Dermatol"},{"key":"2505_CR62","doi-asserted-by":"publisher","first-page":"e9701","DOI":"10.1371\/journal.pone.0009701","volume":"5","author":"M. Romanowska","year":"2010","unstructured":"Romanowska M, Reilly L, Palmer CNA, Gustafsson MCU, Foerster J. Activation of PPARbeta\/delta causes a psoriasis-like skin disease in vivo. PloS one 2010; 5: e9701.","journal-title":"PloS one"},{"key":"2505_CR63","doi-asserted-by":"publisher","first-page":"e37097","DOI":"10.1371\/journal.pone.0037097","volume":"7","author":"K. Hack","year":"2012","unstructured":"Hack K, Reilly L, Palmer C, et al. Skin-targeted inhibition of PPAR \u03b2\/\u03b4 by selective antagonists to treat PPAR -\/\u2014mediated psoriasis-like skin disease in vivo. PloS one 2012; 7: e37097.","journal-title":"PloS one"},{"key":"2505_CR64","doi-asserted-by":"publisher","first-page":"pii858176","DOI":"10.1155\/2010\/858176","volume":"2010","author":"M. Ottaviani","year":"2010","unstructured":"Ottaviani M, Camera E, Picardo M. Lipid mediators in acne. Mediators Inflamm 2010; 2010: pii858176.","journal-title":"Mediators Inflamm"},{"key":"2505_CR65","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1684\/ejd.2011.1575","volume":"22","author":"N.N. Elmongy","year":"2012","unstructured":"Elmongy NN, Shaker O. Expression of peroxisome proliferator activator receptor \u03b2\/\u03b4 (PPAR\u03b2\/\u03b4) in acne vulgaris. Eur J Dermatol 2012; 22: 42\u20135.","journal-title":"Eur J Dermatol"},{"key":"2505_CR66","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/j.1365-2133.2010.10037.x","volume":"164","author":"M. Schuster","year":"2011","unstructured":"Schuster M, Zouboulis CC, Ochsendorf F, et al. Peroxisome proliferator-activated receptor activators protect sebocytes from apoptosis: a new treatment modality for acne? Br J Dermatol 2011; 164: 182\u20136.","journal-title":"Br J Dermatol"},{"key":"2505_CR67","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/35094059","volume":"1","author":"M.J. Bissell","year":"2001","unstructured":"Bissell MJ, Radisky D. Putting tumours in context. Nat Rev Cancer 2001; 1: 46\u201354.","journal-title":"Nat Rev Cancer"},{"key":"2505_CR68","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/nrm2455","volume":"9","author":"M. Sch\u00e4fer","year":"2008","unstructured":"Sch\u00e4fer M, Werner S. Cancer as an overhealing wound: an old hypothesis revisited. Nat Rev Mol Cell Biol 2008; 9: 628\u201338.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2505_CR69","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.cellsig.2006.12.007","volume":"19","author":"A.D. Burdick","year":"2007","unstructured":"Burdick AD, Bility MT, Girroir EE, et al. Ligand activation of peroxisome proliferator-activated receptor-beta\/delta(PPARbeta\/delta) inhibits cell growth of human N\/TERT-1 keratinocytes. Cell Signal 2007; 19: 1163\u201371.","journal-title":"Cell Signal"},{"key":"2505_CR70","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/emm.2004.40","volume":"36","author":"H.R. Seo","year":"2004","unstructured":"Seo HR, Kwan YW, Cho CK, et al. PKCalpha induces differentiation through ERK1\/2 phosphorylation in mouse keratinocytes. Exp Mol Med 2004; 36: 292\u20139.","journal-title":"Exp Mol Med"},{"key":"2505_CR71","doi-asserted-by":"publisher","first-page":"7232","DOI":"10.1158\/1078-0432.CCR-07-1902","volume":"13","author":"S. Kopetz","year":"2007","unstructured":"Kopetz S, Shah AN, Gallick GE. Src continues aging: current and future clinical directions. Clin Cancer Res 2007; 13: 7232\u20136.","journal-title":"Clin Cancer Res"},{"key":"2505_CR72","doi-asserted-by":"publisher","first-page":"E1568","DOI":"10.1210\/jc.2011-1131","volume":"96","author":"E.M.M. Ooi","year":"2011","unstructured":"Ooi EMM, Watts GF, Sprecher DL, Chan DC, Barrett PHR. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity. J Clin Endocrinol Metab 2011; 96: E1568\u201376.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["European Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1684\/ejd.2014.2505.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1684\/ejd.2014.2505\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1684\/ejd.2014.2505.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.jle.com\/10.1684\/ejd.2014.2505","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:19:21Z","timestamp":1741191561000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jle.com\/10.1684\/ejd.2014.2505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":72,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["2505"],"URL":"https:\/\/doi.org\/10.1684\/ejd.2014.2505","relation":{},"ISSN":["1952-4013"],"issn-type":[{"value":"1952-4013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"17 Dezember 2014","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 Juni 2015","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}